PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsurethritis
MeSH D014526 - urethritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014522:Urethral diseases
$
Success rate
D014526: 
Urethritis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAzithromycin Azithromycin  2005-11-14   
Erythromycin C-solve  1993-07-30   
Erythromycin Erythromycin  2021-02-11   
Erythromycin estolate Erythromycin Estolate  1982-01-01   
Erythromycin lactobionate Erythromycin Lactobionate  1993-07-30   
PadagisErythromycin Erythromycin  1983-09-26   
Taro PharmaceuticalErythromycin A/t/s  1982-11-18   
Azithromycin Azithromycin  2019-12-11   
MylanAzithromycin Azithromycin  2007-05-30   
Erythromycin E-glades  2002-03-18   
Erythromycin Erygel  1987-10-21   
Erythromycin Erythromycin  1996-07-03   
Erythromycin stearate Erythromycin Stearate  1982-01-01   
Rising PharmaceuticalsAzithromycin Azithromycin  2007-05-30   
Erythromycin, Benzoyl peroxide Erythromycin Benzoyl Peroxide  2015-09-18   
Johnson & JohnsonErythromycin Erycette  1985-02-15   
Lupin ResearchAzithromycin Azithromycin  2015-05-15   
SandozAzithromycin Azithromycin  2005-11-14   
WyethErythromycin, Erythromycin stearate Wyamycin  1982-01-01   
AlpharmaErythromycin Erythromycin  1982-04-19   
Erythromycin estolate Erythromycin Estolate  1982-11-18   
Erythromycin Erythromycin Ethylsuccinate  1982-01-01   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
75%
3/4
Phase 3
100%
8/8
Approved: 5Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use